Market Cap (In CNY)
3.32 Billion
Revenue (In CNY)
1.3 Billion
Net Income (In CNY)
85.92 Million
Avg. Volume
33.8 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.8-23.55
- PE
- -
- EPS
- -
- Beta Value
- 0.163
- ISIN
- CNE100002N10
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Min Hua Fan
- Employee Count
- -
- Website
- https://english.hnpoly.com
- Ipo Date
- 2017-03-29
- Details
- Hainan Poly Pharm. Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers APIs. The company offers formulations in various therapeutic areas, which include anti-allergy, non-steroid anti-inflammatory, antibiotic, and digestive drugs. Its products include desloratadine preparations in anti-allergy drugs, diclofenac preparations in non-steroidal anti-inflammatory drugs, azithromycin for injection and clarithromycin preparations in antibiotic drugs, and trimebutine maleate preparations in digestive drugs. The company was founded in 1992 and is based in Haikou, China.
More Stocks
-
MDWKMDwerks, Inc.
MDWK
-
BKDP
-
TETAATeton Advisors, LLC
TETAA
-
9995RemeGen Co., Ltd.
9995
-
LTOUFLarsen & Toubro Limited
LTOUF
-
FHELFFirst Helium Inc.
FHELF
-
601975Nanjing Tanker Corporation
601975
-
AHT-PG